Notify me when Esther Rajavelu files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SPRO | Spero Therapeutics, Inc. | Chief Executive Officer, Chief Financial Officer and Chief Business Officer | $2.06M | -$112K | -5.14% | Nov 7, 2025 |
| FULC | Fulcrum Therapeutics, Inc. | Chief Financial Officer | Feb 9, 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|